Posted By:Tom Brennan
The CEO tells us whether or not a new cutting-edge cancer treatment could send this stock to its 2000-era level.
Read More
Read MoreTopics:CEOs and CFOs | Stock Picks | Stock Market
Companies:Genentech, Inc. | ImmunoGen, Inc.

